Altimmune (ALT) Shares Outstanding (Entity) (2010 - 2026)

Altimmune (ALT) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Altimmune 571.75 Mn 571.75 Mn - 194.47 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 194.47 Mn
Mar 31, 2026 130.22 Mn
Dec 31, 2025 88.10 Mn
Sep 30, 2025 95.60 Mn
Jun 30, 2025 85.08 Mn
Mar 31, 2025 77.83 Mn
Dec 31, 2024 72.35 Mn
Sep 30, 2024 71.12 Mn
Jun 30, 2024 71.05 Mn
Mar 31, 2024 70.90 Mn
Dec 31, 2023 53.25 Mn
Sep 30, 2023 52.86 Mn
Jun 30, 2023 52.66 Mn
Mar 31, 2023 49.29 Mn
Dec 31, 2022 49.20 Mn
Sep 30, 2022 49.16 Mn
Jun 30, 2022 46.37 Mn
Mar 31, 2022 43.22 Mn
Dec 31, 2021 40.99 Mn
Sep 30, 2021 39.70 Mn